Charlotta Wallinder

827 total citations
19 papers, 692 citations indexed

About

Charlotta Wallinder is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Charlotta Wallinder has authored 19 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Charlotta Wallinder's work include Receptor Mechanisms and Signaling (15 papers), Renin-Angiotensin System Studies (14 papers) and Neuropeptides and Animal Physiology (7 papers). Charlotta Wallinder is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Renin-Angiotensin System Studies (14 papers) and Neuropeptides and Animal Physiology (7 papers). Charlotta Wallinder collaborates with scholars based in Sweden, Canada and Australia. Charlotta Wallinder's co-authors include Anders Hallberg, Nicole Gallo‐Payet, Mathias Alterman, Fred Nyberg, Xiongyu Wu, Yiqian Wan, Marie‐Odile Guimond, Anders Karlén, Hélène Beaudry and M. Arulprakasajothi and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Charlotta Wallinder

19 papers receiving 683 citations

Peers

Charlotta Wallinder

CCM

EDM

CMN

Catherine Cazaubon France

Gillian M. Olins United States

Magdi M. Asaad United States

Wendy Tomlinson United Kingdom

Hamiyet Ünal United States

Christopher S. Konkoy United States

Shin-ichiro Miura United States

Marie Claude Fournié-Zaluski France

Ross Bentley United States

Anthony H. Ingall United Kingdom

Catherine Cazaubon France

Charlotta Wallinder

466 ×1.1

CCM

389 ×1.0

219 ×1.0

EDM

65 ×0.6

CMN

105 ×1.0

Citations per year, relative to Charlotta Wallinder Charlotta Wallinder (= 1×) peers Catherine Cazaubon

Countries citing papers authored by Charlotta Wallinder

Since Specialization

Citations

This map shows the geographic impact of Charlotta Wallinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Wallinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Wallinder more than expected).

Fields of papers citing papers by Charlotta Wallinder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Wallinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Wallinder. The network helps show where Charlotta Wallinder may publish in the future.

Co-authorship network of co-authors of Charlotta Wallinder

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Wallinder. A scholar is included among the top collaborators of Charlotta Wallinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Wallinder. Charlotta Wallinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wallinder, Charlotta, Christian Sköld, Marie‐Odile Guimond, et al.. (2019). High affinity rigidified AT₂ receptor ligands with indane scaffolds. MedChemComm. 10(12). 2146–2160. 7 indexed citations

Sallander, Jessica, Charlotta Wallinder, Anders Hallberg, Johan Åqvist, & Hugo Gutiérrez‐de‐Terán. (2015). Structural determinants of subtype selectivity and functional activity of angiotensin II receptors. Bioorganic & Medicinal Chemistry Letters. 26(4). 1355–1359. 16 indexed citations

Wallinder, Charlotta, Anna Więckowska, Marie‐Odile Guimond, et al.. (2014). N‐Aryl Isoleucine Derivatives as Angiotensin II AT₂ Receptor Ligands. ChemistryOpen. 3(2). 65–75. 3 indexed citations

Wallinder, Charlotta, Christian Sköld, Milad Botros, et al.. (2014). Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT₂ Receptor Ligands. ACS Medicinal Chemistry Letters. 6(2). 178–182. 13 indexed citations

Guimond, Marie‐Odile, Mathias Hallberg, Nicole Gallo‐Payet, & Charlotta Wallinder. (2014). Saralasin and Sarile Are AT₂ Receptor Agonists. ACS Medicinal Chemistry Letters. 5(10). 1129–1132. 19 indexed citations

Wallinder, Charlotta, et al.. (2013). Synthesis and evaluation of isoleucine derived angiotensin II AT2 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 24(2). 476–479. 4 indexed citations

Wannberg, Johan, et al.. (2013). One-Pot, Two-Step, Microwave-Assisted Palladium-Catalyzed Conversion of Aryl Alcohols to Aryl Fluorides via Aryl Nonaflates. The Journal of Organic Chemistry. 78(8). 4184–4189. 31 indexed citations

Guimond, Marie‐Odile, Charlotta Wallinder, Mathias Alterman, Anders Hallberg, & Nicole Gallo‐Payet. (2012). Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT2) receptor. Effects on neurite outgrowth in NG108-15 cells. European Journal of Pharmacology. 699(1-3). 160–171. 26 indexed citations

Shum, Michaël, Marie‐Odile Guimond, Sébastien M. Labbé, et al.. (2012). Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology-Endocrinology and Metabolism. 304(2). E197–E210. 52 indexed citations

10.

Wu, Xiongyu, Charlotta Wallinder, M. Arulprakasajothi, et al.. (2012). From the First Selective Non-Peptide AT₂Receptor Agonist to Structurally Related Antagonists. Journal of Medicinal Chemistry. 55(5). 2265–2278. 34 indexed citations

11.

Gallo‐Payet, Nicole, Michaël Shum, Jean‐Patrice Baillargeon, et al.. (2012). AT2 Receptor Agonists: Exploiting the Beneficial Arm of Ang II Signaling. Current Hypertension Reviews. 8(1). 47–59. 16 indexed citations

12.

Steckelings, U. Muscha, Mats Larhed, Anders Hallberg, et al.. (2010). Non-peptide AT2-receptor agonists. Current Opinion in Pharmacology. 11(2). 187–192. 84 indexed citations

13.

Arulprakasajothi, M., Yiqian Wan, Charlotta Wallinder, et al.. (2010). Selective angiotensin II AT2 receptor agonists with reduced CYP 450 inhibition. Bioorganic & Medicinal Chemistry. 18(12). 4570–4590. 18 indexed citations

14.

Åberg, Ola, Marc Y. Stevens, Jonas Lindh, et al.. (2010). Synthesis and evaluation of a ¹¹C‐labelled angiotensin II AT₂ receptor ligand. Journal of Labelled Compounds and Radiopharmaceuticals. 53(10). 616–624. 9 indexed citations

15.

Wallinder, Charlotta, Milad Botros, Ulrika Rosenström, et al.. (2008). Selective angiotensin II AT2 receptor agonists: Benzamide structure–activity relationships. Bioorganic & Medicinal Chemistry. 16(14). 6841–6849. 26 indexed citations

16.

Rosenström, Ulrika, Charlotta Wallinder, Hélène Beaudry, et al.. (2006). Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity. Bioorganic & Medicinal Chemistry. 14(17). 5963–5972. 15 indexed citations

17.

Wan, Yiqian, Charlotta Wallinder, Berndt Johansson, et al.. (2004). First Reported Nonpeptide AT₁Receptor Agonist (L-162,313) Acts as an AT₂Receptor Agonist in Vivo. Journal of Medicinal Chemistry. 47(6). 1536–1546. 36 indexed citations

18.

Wan, Yiqian, Charlotta Wallinder, Bianca Plouffe, et al.. (2004). Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT₂ Receptor Agonist. Journal of Medicinal Chemistry. 47(24). 5995–6008. 276 indexed citations

19.

Gullbo, Joachim, Charlotta Wallinder, Henrik Lövborg, et al.. (2003). Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2.. PubMed. 2(12). 1331–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact